Avidity Partners Management LP decreased its stake in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 11.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 710,000 shares of the biopharmaceutical company’s stock after selling 91,100 shares during the period. Intra-Cellular Therapies accounts for about […]
Avidity Partners Management LP decreased its stake in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 11.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 710,000 shares of the biopharmaceutical company’s stock after selling 91,100 shares during the period. Intra-Cellular Therapies accounts for about […]
AdvisorShares Investments LLC lowered its holdings in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 28.1% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 4,151 shares of the biopharmaceutical company’s stock after selling 1,621 shares during the period. AdvisorShares Investments LLC’s holdings in Intra-Cellular Therapies were worth $297,000 at the end of the […]
Sectoral Asset Management Inc. cut its position in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 94.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 7,420 shares of the biopharmaceutical company’s stock after selling 116,260 shares during the period. Sectoral Asset Management Inc.’s holdings […]
Rhenman & Partners Asset Management AB reduced its stake in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) by 5.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 90,000 shares of the biopharmaceutical company’s stock after selling 5,000 shares during the […]